Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
| Autor: | Masoud Etemadifar, Davood Ommi, Sepand Tehrani Fateh, Zahra Aminzade, Farzad Ashrafi, Mehri Salari |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Parkinson's disease Coronavirus disease 2019 (COVID-19) Referral Disease Iran symbols.namesake Internal medicine Correspondence Humans Medicine Mortality Fisher's exact test Aged Principal Component Analysis business.industry COVID-19 Parkinson Disease Middle Aged University hospital medicine.disease Survival Analysis Pathophysiology Hospitalization Increased risk Neurology symbols Dementia Neurology (clinical) Geriatrics and Gerontology business |
| Zdroj: | Parkinsonism & Related Disorders |
| ISSN: | 1353-8020 |
| Popis: | Background Parkinson's disease (PD) patients may be at increased risk of Covid-19 mortality due to the nature of their disease or underlying conditions. Method The information of 12,909 Covid-19 patients who were hospitalized during the last eleven months were collected from the data depository of two referral university hospitals. Eighty-seven of these patients were diagnosed with PD, and thirty-one of these PD patients died because of Covid-19. 2132 other deaths occurred in these centers, related to Covid-19 of non-PD patients. Fisher exact test, Chi-square test, and Principle component analysis were used for statistical analysis. Results The mortality among PD patients and other hospitalized patients was 35.6% and 19.8%, respectively, and the difference between the mortality of these two groups was found to be statistically significant (p-value0.05). Alzheimer's disease as an underlying condition was more frequent in deceased PD patients in comparison to survived PD patients, and this difference was found to be statistically significant (p-value |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect